A groundbreaking FDA approval has introduced a new treatment option specifically designed for colorectal cancer patients with ...
Colon cancer rates are surging worldwide, especially among younger and relatively healthy people, making it more important ...
The accelerated approval is part of the FDA’s Project FrontRunner, aimed at advancing cancer drug development.
Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...
Colon cancer screening is only effective if you complete the test. With 53,000 Americans expected to die from colon cancer in ...